Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
4.290
-0.500 (-10.44%)
At close: Jun 5, 2026, 4:00 PM EDT
4.270
-0.020 (-0.47%)
After-hours: Jun 5, 2026, 5:35 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $103.65 million as of June 5, 2026. Its market cap has decreased by -20.43% in one year.
Market Cap
103.65M
Enterprise Value
109.28M
1-Year Change
-20.43%
Ranking
Category
Stock Price
$4.29
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $103.65M, an increase of 64.24%. That is a compound annual growth rate of 7.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 115.73M | -16.01% |
| Dec 31, 2025 | 137.79M | 90.55% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Castle Biosciences | 639.36M |
| Fulgent Genetics | 541.17M |
| Myriad Genetics | 431.63M |
| Prenetics Global | 334.21M |
| Insight Molecular Diagnostics | 169.19M |
| Biodesix | 159.77M |
| Burning Rock Biotech | 97.13M |
| Precipio | 42.30M |